Everist Genomics Forms Joint Venture Targeting Indian Market | GenomeWeb

NEW YORK (GenomeWeb News) – Everist Genomics today announced a joint venture with Manipal Group to establish a business presence in India.

The joint venture will market Everist's diagnostic, prognostic, and therapeutic solutions through Manipal's healthcare network in India, which includes 15 hospitals, nine primary care clinics, and 55 community health centers. Additionally, the deal leverages Manipal's background in medical products, commercially viable infrastructure, and capabilities in the region, Everist said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.